Literature DB >> 19848604

Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors.

Marya D Zilberberg1, Andrew F Shorr, Scott T Micek, Alex P Hoban, Victor Pham, Joshua A Doherty, Andrew M Ramsey, Marin H Kollef.   

Abstract

OBJECTIVE: Healthcare-associated infections are likely to be caused by drug-resistant and possibly mixed organisms and to be treated with inappropriate antibiotics. Because prompt appropriate treatment is associated with better outcomes, we studied the epidemiology of healthcare-associated complicated skin and skin-structure infections (cSSSIs). PATIENTS: Persons hospitalized with cSSSI and a positive culture result.
METHODS: We conducted a single-center retrospective cohort study from April 2006 through December 2007. We differentiated healthcare-associated from community-acquired cSSSIs by at least 1 of the following risk factors: (1) recent hospitalization, (2) recent antibiotics, (3) hemodialysis, and (4) transfer from a nursing home. Inappropriate treatment was defined as no antimicrobial therapy with activity against the offending pathogen(s) within 24 hours after collection of a culture specimen. Mixed infections were those caused by both a gram-positive and a gram-negative organism.
RESULTS: Among 717 hospitalized patients with cSSSI, 527 (73.5%) had healthcare-associated cSSSI. Gram-negative organisms were more common (relative risk, 1.24 [95% confidence interval, 1.14-1.35) and inappropriate treatment trended toward being more common (odds ratio, 1.29 [95% confidence interval, 0.85-1.95]) in healthcare-associated cSSSI than in community-acquired cSSSI. Mixed cSSSIs occurred in 10.6% of patients with healthcare-associated cSSSI and 6.3% of those with community-acquired cSSSI (P = .082) and were more likely to be treated inappropriately than to be nonmixed infections (odds ratio, 2.42 [95% confidence interval, 1.43-4.10]). Both median length of hospital stay (6.2 vs 2.9 days; P < .001) and mortality rate (6.6% vs 1.1%; P = .003) were significantly higher for healthcare-associated cSSSI than community-acquired cSSSI.
CONCLUSIONS: Healthcare-associated cSSSIs are common and are likely to be caused by gram-negative organisms. Mixed infections carry a >2-fold greater risk of inappropriate treatment. Healthcare-associated cSSSIs are associated with increased mortality and prolonged length of hospital stay, compared with community-acquired cSSSIs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19848604     DOI: 10.1086/648083

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

1.  Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.

Authors:  Marcus J Zervos; Katherine Freeman; Lien Vo; Nadia Haque; Hiren Pokharna; Monika Raut; Myoung Kim
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

Review 2.  Pillars for prevention and control of healthcare-associated infections: an Italian expert opinion statement.

Authors:  Vincenzo Puro; Nicola Coppola; Andrea Frasca; Ivan Gentile; Francesco Luzzaro; Angela Peghetti; Gabriele Sganga
Journal:  Antimicrob Resist Infect Control       Date:  2022-06-20       Impact factor: 6.454

3.  Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study.

Authors:  Hsiu-Nien Shen; Chin-Li Lu
Journal:  BMC Infect Dis       Date:  2010-06-04       Impact factor: 3.090

4.  Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections.

Authors:  Marya D Zilberberg; Paresh Chaudhari; Brian H Nathanson; Rebecca S Campbell; Matthew F Emons; Suzanne Fiske; Harlen D Hays; Andrew F Shorr
Journal:  BMC Infect Dis       Date:  2012-07-11       Impact factor: 3.090

5.  Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole.

Authors:  April Barbour; Hartmut Derendorf
Journal:  Ther Clin Risk Manag       Date:  2010-10-05       Impact factor: 2.423

6.  Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates.

Authors:  Ashraf El Houfi; Nadeem Javed; Caitlyn T Solem; Cynthia Macahilig; Jennifer M Stephens; Nirvana Raghubir; Richard Chambers; Jim Z Li; Seema Haider
Journal:  Infect Drug Resist       Date:  2015-06-18       Impact factor: 4.003

7.  Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013.

Authors:  Xiaoyan Li; Yunqin Chen; Weiguo Gao; Wenwei Ouyang; Jia Wei; Zehuai Wen
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

8.  A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.

Authors:  William O'Riordan; Alison McManus; Juri Teras; Ivan Poromanski; Maria Cruz-Saldariagga; Megan Quintas; Laura Lawrence; ShuJui Liang; Sue Cammarata
Journal:  Clin Infect Dis       Date:  2018-08-16       Impact factor: 9.079

9.  A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes.

Authors:  Benjamin A Lipsky; Gregory J Moran; Lena M Napolitano; Lien Vo; Susan Nicholson; Myoung Kim
Journal:  BMC Infect Dis       Date:  2012-09-25       Impact factor: 3.090

10.  Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study.

Authors:  Gary Thomas Ray; Jose Antonio Suaya; Roger Baxter
Journal:  BMC Infect Dis       Date:  2013-05-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.